Herrstedt, J. http://orcid.org/0000-0002-8844-6546
Clark-Snow, R.
Ruhlmann, C. H.
Jordan, K.
Scotté, F.
Article History
First Online: 22 December 2023
Declarations
:
: JH has received honoraria as a consultant for Pharmathen S.A.RC-S has reported no potential conflicts of interest.CHR has received honoraria (speaker) from Bristol Myers Squibb (BMS), Helsinn Healthcare SA and Pharmanovia and funding for a clinical trial from Helsinn Healthcare SA and the Novo Nordic Foundation.KJ reports personal fees as an invited speaker from Amgen, Art Tempi, Helsinn Healthcare SA, Hexal, Med Update GmbH, MSD, Mundipharma, Onkowissen, Esteve, Roche, Shire (Takeda) and Vifor; personal fees for advisory board membership from Amgen, AstraZeneca, BD Solutions, Hexal, Karyopharm and Voluntis; personal fees as author for UpTo Date.F Scotté reports personal fees from Alliance Healthcare, Amgen, Biogaran, BMS, Helsinn, Leo Pharma, MSD, Mundipharma, Pfizer, Pierre Fabre Oncology, Pharmanovia, Sandoz, Sanofi, Thermofisher and Viatris.
Free to read: This content has been made available to all.